核酸単離・精製市場：製品、方法、タイプ、用途、エンドユーザー別-2024-2030年世界予測

核酸単離・精製市場規模は2023年に69億4,000万米ドルと推定され、2024年には75億8,000万米ドルに達し、CAGR 9.59%で2030年には131億8,000万米ドルに達すると予測されます。

核酸の単離・精製は、分子生物学、遺伝学、バイオテクノロジーにおける基本的な技術で、細胞、組織、生物からDNAやRNAを含む高品質の核酸を抽出します。このプロセスには、これらの必須生体分子をタンパク質、脂質、炭水化物、および下流のアプリケーションの潜在的阻害物質から分離するステップが含まれます。シリカベースのマトリックスや陰イオン交換樹脂を用いたカラムクロマトグラフィー、有機溶媒抽出、塩やアルコールを用いた沈殿、磁気ビーズを用いた分離など、いくつかの分離技術が、核酸のサイズ、電荷、配列特異性に基づく選択的な結合と溶出のために採用されます。分子生物学およびバイオテクノロジー研究の基礎となる技術であり、科学者が遺伝子情報を分子レベルで研究し、細胞メカニズムを解明し、医学、農業、環境科学などさまざまな分野で革新的なソリューションを開発することを可能にします。同市場は、主に製薬およびバイオテクノロジー産業における純粋核酸の需要の高まり、有利な政府ガイドラインおよび規制、遺伝子工学、生命科学研究、法医学に対する資金調達の増加によって、大きな成長を遂げています。しかし、核酸の分離・精製施設を設置するためのコストが高く、専門知識が不足していることが市場開拓の妨げになる可能性があります。とはいえ、核酸抽出・精製技術における技術革新の急増や、動植物細胞からのDNA抽出における潜在的な進歩が、このダイナミックな市場空間におけるさらなる可能性を引き出しています。

製品ルーチン作業の時間を短縮する自動化機器への需要の高まり

核酸分離精製機器は、さまざまな種類のサンプルから核酸を効率的かつ確実に抽出・精製するために不可欠です。このような機器は、遠心分離機、サーモサイクラー、マイクロプレートリーダー、分光システムなど多岐にわたり、高い収率と精度を保証するサンプルコンタミネーションの低減に役立っています。キットは、核酸の単離と精製のための"オール・イン・ワン"ソリューションを提供するもので、通常、バッファー、試薬、分離ツールなどの必要なコンポーネントがすべて含まれています。これらは、効率的な細胞溶解、核酸の精製マトリックスへの結合、洗浄、溶出を達成するために注意深く設計されています。処理できるサンプルの種類、分離に必要な時間、必要な機器のレベルは様々です。核酸の単離と精製に使用される試薬は通常、細胞や組織の溶解、タンパク質や汚染物質の除去、核酸の沈殿や溶出という特定の機能を果たします。これらには有機溶媒、塩、洗浄剤、酵素などが含まれます。使用される試薬の質は、単離され精製された核酸の収量と完全性に直接影響します。自動装置か手動キットかの選択は、操作の規模、人件費、作業の時間的敏感さによって決まる。同様に、試薬の選択は、原料の性質と核酸の望ましい純度に影響される可能性があります。

方法カラムベースの単離・精製はスケーラビリティに優れており、サンプルサイズに関係なく効果的な精製・単離が可能です。

カラムベースの分離・精製は、シリカベースのカラムを用いたサイズ排除クロマトグラフィーの原理に依存しています。核酸はカオトロピック塩の存在下でシリカマトリックスに選択的に結合し、汚染物質はカラムを通過します。その後の洗浄および溶出工程で、純粋な核酸がカラムから放出されます。この方法は、高収率、高純度、そして様々なサンプルタイプで一貫した結果を提供します。磁気ビーズベースの分離精製では、特定の条件下で核酸に結合する機能化磁気ビーズを利用します。サンプルはこれらのビーズと混合され、核酸がその表面に付着します。その後、溶液中の汚染物質からビーズに結合した核酸を分離するために磁石を使用します。この方法は、様々なサンプルサイズやスループット要件に対して優れたスケーラビリティと柔軟性を提供し、クローズドチューブ形式であるため交差汚染のリスクを低減します。試薬ベースの分離・精製では、フェノール-クロロホルムまたはグアニジニウムチオシアネート-フェノール-クロロホルム混合物のような試薬が使用され、相分離条件下で溶解度の違いを介してタンパク質から核酸を分離します。遠心分離後、エタノールまたはイソプロパノールを用いた沈殿により、水相から核酸を回収することができます。その選択は、プロジェクトの特定の要件に大きく依存します。カラムベースの分離・精製はスケーラビリティと高純度を提供し、磁気ビーズベースの分離は再現性とハイスループットなアプリケーションに適しています。

タイプ

循環核酸の単離と精製は、主に血漿または血清から循環無細胞DNA（cfDNA）とRNAを単離します。ゲノムDNAの単離と精製は、ゲノムからDNAを抽出することに重点を置いており、遺伝情報の包括的なマップが得られます。精製されたゲノムDNAは、遺伝学、薬理ゲノミクス、疾患研究など様々な分野で応用されています。メッセンジャーRNAの単離・精製はメッセンジャーRNA（mRNA）を対象とし、この技術は遺伝子制御の研究において重要な役割を果たしています。遺伝子発現プロファイルに関する重要な洞察を提供し、がんや神経疾患の治療研究に役立ちます。マイクロRNAの単離と精製は、遺伝子発現を制御する小さなノンコーディングRNA分子であるマイクロRNA（miRNA）に焦点を当てています。miRNAの探索は、特に腫瘍学、心臓病学、ウイルス学など、分子レベルでの疾患の理解に深い意味を持っています。PCRクリーンアップはPCR増幅産物を精製する技術です。プライマー、ヌクレオチド、酵素、塩類を除去することが重要であり、これらはその後の酵素反応を阻害する可能性があります。プラスミドDNAの単離と精製プラスミドDNAの単離をターゲットとすることは、遺伝子工学や遺伝子クローニングに不可欠です。遺伝子キャリアーとしてのプラスミドは、遺伝子治療やワクチン開発など、バイオテクノロジー的に重要な用途があります。トータルRNA分離精製法は、mRNA、tRNA、rRNAを含むあらゆるタイプのRNAを得ることを目的としています。これは様々な研究分野において極めて重要であり、特に遺伝子の機能、構造、発現を理解するためのトランスクリプトームの探索において重要です。このように、単離精製法の選択は、特定の核酸の種類と研究の必要性に左右されます。このような技術の進歩は、ゲノム・遺伝学研究領域における前例のない機会を活性化し、その範囲を絶えず広げています。

応用診断学における核酸単離・精製の幅広い応用による治療の指針の提供します。

農業や動物の研究において、核酸は遺伝子組み換え作物（GMO）の検出、作物や家畜の病原菌の特定、望ましい形質の選択育種の促進に役立っています。核酸抽出技術の研究開発により、研究者は病気を早期に発見し、感染した植物や動物に対する効果的な治療戦略を開発できるようになった。診断学では、核酸の迅速な単離・精製は、細菌やウイルスなどの感染因子を特定するために不可欠であり、医療従事者が病気を診断し、タイムリーな医療介入を的確に行えるよう支援しています。創薬と薬剤開発は、特定の疾患に関連する標的分子を同定するために核酸分析に大きく依存しています。研究者は、新しい治療化合物に対する遺伝子の挙動を調べることによって、薬剤の有効性を評価し、潜在的な副作用を予測することができます。個別化医療では、核酸情報を患者の遺伝的体質に基づいて個別化された治療を調整するために使用します。このアプローチにより、ヘルスケア提供者は、薬物代謝や特定の疾患に対する素因などの要因を考慮することで、治療レジメンを最適化することができます。その結果、個別化医療は、潜在的な副作用を減らしながら治療結果の改善を約束します。

エンドユーザー：信頼性の高い結果と迅速な納期を求めるCROによる核酸単離・精製の利用拡大

学術機関や政府研究機関では、遺伝学や分子生物学の研究に核酸の分離精製技術を主に使用しています。そこでは、厳しい品質基準と、課題も含めた幅広い種類のサンプルを扱う能力が重要です。開発業務受託機関（CRO）は、正確でハイスループットな核酸分離が不可欠な創薬、前臨床試験、臨床試験に定期的に取り組んでいます。CROは、信頼性の高い結果、拡張性、迅速な納期を備えたソリューションを求めています。臨床診断では、精製プロトコルの精度と安定性が不可欠です。患者ケアにおける遺伝子検査や個別化医療の重要性が高まる中、病院や診断センターはより迅速で高感度、拡張性のあるキットを必要としています。製薬会社やバイオテクノロジー企業は、新規治療薬や診断アッセイの開発に取り組むことが多いです。特に診断薬、ワクチン、バイオ医薬品の製造においては、核酸単離に高い信頼性とスケーラブルな技術が要求されます。どのエンドユーザーも信頼性、拡張性、迅速な納期を重視しますが、それぞれの業務分野に特有の要件があります。メーカーが核酸分離精製技術を向上させるには、これらのニーズを考慮することが不可欠です。

地域別の洞察

南北アメリカでは、バイオテクノロジーと製薬部門における旺盛な研究開発投資と遺伝性疾患の増加によって市場が活性化しています。分子生物学的技術の増加、慢性疾患の有病率の上昇、個別化医療のニーズの加速が、この地域における核酸抽出法のニーズを高めています。さらに、Thermo Fisher Scientific Inc.、QIAGEN N.V.、Illumina Inc.などの主要企業の存在が、研究室や診断センターからの需要増に対応するための製品革新を後押ししています。EMEA地域は、欧州の高齢化社会における政府および民間団体による医療支出の増加により、大きな進展を見せています。また、中東・アフリカ諸国は医療インフラ整備プロジェクトに多額の投資を行っており、地域の市場展望をさらに高めています。数多くの大学や研究機関の協力も、核酸分離法の科学的進歩を加速させています。APAC地域は、ヘルスケア分野の急速な開拓、ライフサイエンス研究に対する政府支援の増加、高い人口基盤により、核酸単離・精製市場拡大の大きな可能性を秘めています。さらに、中国、インド、日本、韓国、オーストラリアなどの新興国は、業界の利害関係者が未開拓の成長可能領域を開拓する有利な機会を提供しています。結論として、核酸単離・精製市場は、技術の進歩、効率的な診断と治療介入を必要とする疾患有病率の増加により、南北アメリカ、EMEA、APACの各地域でプラスの傾向を示しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは核酸単離・精製市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、核酸単離・精製市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.核酸単離・精製市場の市場規模および予測は？

2.核酸単離・精製市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.核酸単離・精製市場の技術動向と規制枠組みは？

4.核酸単離・精製市場における主要ベンダーの市場シェアは？

5.核酸単離・精製市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬業界およびバイオテクノロジー業界における純粋な核酸の需要の高まり
    • DNA抽出プロセスに関する政府の好ましいガイドラインと規制
    • 遺伝子工学、生命科学調査、法医学への資金提供の増加
  • 抑制要因
    • 核酸単離・精製のセットアップコストが高い
  • 機会
    • 核酸抽出および精製技術における新たなイノベーション
    • 植物や動物の細胞からDNAを抽出するための潜在的な開発
  • 課題
    • 核酸分野における専門知識の欠如
• 市場セグメンテーション分析
  • 製品：日常業務の時間を短縮する自動化機器の需要が高まっています
  • 方法：スケーラビリティを考慮したカラムベースの分離・精製の大幅な採用により、サンプルサイズに関係なく効果的な精製と分離が可能

第5章 2.3.タイプ：

• 応用：治療の指針を提供するための診断における核酸単離・精製の幅広い応用
• エンドユーザー：信頼性の高い結果と迅速な処理時間のために、CROによる核酸単離・精製の使用が増加しています。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 核酸単離・精製市場：製品別

• 機器
• キット
• 試薬

第7章 核酸単離・精製市場：方法別

• カラムベースの分離と精製
• 磁気ビーズによる分離と精製
• 試薬ベースの分離と精製

第8章 核酸単離・精製市場：タイプ別

• 循環する核酸単離・精製
• ゲノムDNAの分離と精製
• メッセンジャーRNAの分離と精製
• マイクロRNAの分離と精製
• PCRクリーンアップ
• プラスミドDNAの分離と精製
• 全RNAの分離と精製

第9章 核酸単離・精製市場：用途別

• 農業と動物調査
• 診断
• 医薬品の発見と開発
• 個別化医療

第10章 核酸単離・精製市場：エンドユーザー別

• 学術機関および政府調査機関
• 契約調査機関
• 病院と診断センター
• 製薬・バイオテクノロジー企業

第11章 南北アメリカの核酸単離・精製市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の核酸単離・精製市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの核酸単離・精製市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • BioEcho、FFPEサンプルからのDNA抽出を簡素化するEchoLUTION FFPE DNAキットを発売
  • Invitek MolecularがALS Limitedに買収される
  • バイオナノ・ゲノミクスがピュリゲン・バイオシステムズを買収し、光学ゲノムマッピング（OGM）のDNA分離をさらに簡素化・加速化し、イオン精製システムによる等速電気泳動（ITP）を用いた新しいアプリケーションで扱いにくいサンプルタイプに対応
• 戦略分析と提言

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. NUCLEIC ACID ISOLATION & PURIFICATION MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. NUCLEIC ACID ISOLATION & PURIFICATION MARKET DYNAMICS
• FIGURE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. NUCLEIC ACID ISOLATION & PURIFICATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN-BASED ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN-BASED ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD-BASED ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD-BASED ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REAGENT-BASED ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REAGENT-BASED ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CIRCULATING NUCLEIC ACID ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CIRCULATING NUCLEIC ACID ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENOMIC DNA ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENOMIC DNA ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MESSENGER RNA ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MESSENGER RNA ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MICRO RNA ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MICRO RNA ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR CLEANUP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR CLEANUP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PLASMID DNA ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PLASMID DNA ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TOTAL RNA ISOLATION & PURIFICATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TOTAL RNA ISOLATION & PURIFICATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 63. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 64. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 73. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 74. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 91. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 92. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 93. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 94. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 95. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 100. CANADA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 107. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 117. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 135. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 136. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 137. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 138. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 139. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 140. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 141. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 145. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 146. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 147. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 148. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 149. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 154. CHINA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 155. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 156. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 157. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 158. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 159. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 160. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 161. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 164. INDIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 165. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 166. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 167. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 168. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 169. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 174. INDONESIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 175. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 176. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 177. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 178. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 179. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 180. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 181. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 184. JAPAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 185. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 188. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 189. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 190. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 191. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 194. MALAYSIA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 195. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 196. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 197. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 198. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 199. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 204. PHILIPPINES NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 205. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 206. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 207. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 208. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 209. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 210. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 211. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 214. SINGAPORE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 216. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 218. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 220. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 224. SOUTH KOREA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 225. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 226. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 227. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 228. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 229. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 234. TAIWAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 235. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 238. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 239. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 240. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 241. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 244. THAILAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 245. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 246. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 247. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 248. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 249. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 250. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 251. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 254. VIETNAM NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 267. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 270. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 271. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 276. DENMARK NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 277. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 278. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 279. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 280. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 281. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 282. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 283. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
• TABLE 286. EGYPT NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
• TABLE 287. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 288. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 289. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
• TABLE 290. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
• TABLE 291. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 292. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 293. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 294. FINLAND NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 20

[181 Pages Report] The Nucleic Acid Isolation & Purification Market size was estimated at USD 6.94 billion in 2023 and expected to reach USD 7.58 billion in 2024, at a CAGR 9.59% to reach USD 13.18 billion by 2030.

Nucleic acid isolation and purification is a basic technique in molecular biology, genetics, and biotechnology to extract high-quality nucleic acids, including DNA and RNA, from cells, tissues, or organisms. This process involves steps that separate these essential biomolecules from proteins, lipids, carbohydrates, and potential inhibitors of downstream applications. Several separation techniques, such as column chromatography with silica-based matrices or anion-exchange resins, organic solvent extraction, precipitation using salts or alcohol, and magnetic bead-based separation, can be employed for the selective binding and elution of nucleic acids based on their size, charge, or sequence specificity. Nucleic acid isolation & purification is a cornerstone technique for molecular biology and biotechnology research, enabling scientists to study genetic information at a molecular level, elucidate cellular mechanisms, and develop innovative solutions across various fields, including medicine, agriculture, and environmental science. The market is experiencing significant growth, driven primarily by the rising demand for pure nucleic acids in pharmaceutical and biotechnological industries, favorable government guidelines and regulations, and rising funding for genetic engineering, life science research, and forensics. However, the high cost of setting up nucleic acid isolation and purification facilities and the lack of subject expertise may hinder the market development. Nevertheless, surging innovations in nucleic acid extraction and purification techniques and potential advancements in extracting DNA from plant and animal cells unlock further potential in this dynamic market space.

Product: Growing demand for automation instruments to reduce the time for routine tasks

Nucleic acid isolation and purification instruments are crucial for efficient and reliable extraction and purification of nucleic acids from various types of samples. Such instruments range from centrifuges, thermocyclers, microplate readers, and spectroscopy systems, which aid in reducing sample contamination ensuring high yields and precision. Kits provide an 'all in one' solution for nucleic acid isolation and purification, typically including all necessary components such as buffers, reagents, and separation tools. These are carefully designed to achieve efficient cell lysis, binding of nucleic acids to a purification matrix, washing, and elution. They can vary in the type of sample they're able to process, the time required for isolation, and the level of equipment needed. Reagents used in nucleic acid isolation and purification typically serve specific functions, the lysis of cells and tissues, the removal of proteins and contaminants, and the precipitation or elution of the nucleic acids. These include organic solvents, salts, detergents, and enzymes. The quality of reagents used directly impacts the yield and integrity of the isolated and purified nucleic acids. The choice between an automated instrument or a manual kit might depend on the scale of operations, labor costs, and the time-sensitivity of tasks. Similarly, the choice of reagents could be influenced by the source material's nature and the nucleic acids' desired purity.

Method: Significant adoption of column-based isolation & purification owing to scalability, allowing effective purification and isolation irrespective of the sample size

Column-based isolation & purification relies on the principle of size exclusion chromatography by using silica-based columns. Nucleic acids bind selectively to the silica matrix in the presence of chaotropic salts while contaminants pass through the column. Subsequent washing and elution steps release pure nucleic acids from the column. This method offers high yield, purity, and consistent results across various sample types. Magnetic bead-based isolation & purification utilizes functionalized magnetic beads that bind to nucleic acids under certain conditions. The sample is mixed with these beads, allowing nucleic acids to attach to their surface. A magnet is then applied to separate the bead-bound nucleic acids from contaminants within the solution. This method provides excellent scalability and flexibility for various sample sizes and throughput requirements and reduces cross-contamination risks due to its closed-tube format. Reagent-based isolation & purification involves reagents such as phenol-chloroform or guanidinium thiocyanate-phenol-chloroform mixtures that separate nucleic acids from proteins via solubility differences under phase separation conditions. After centrifugation, nucleic acids can be recovered from the aqueous phase through precipitation using ethanol or isopropanol. The choice largely depends on the particular requirements of your project. Column-Based isolation & purification offers scalability and high purity, magnetic bead-based isolation favors reproducibility and high-throughput applications, and reagent-based isolation is more economical and suitable for large-scale isolation despite its possible limitations in purity.

Type:

Circulating nucleic acid isolation and purification primarily involves isolating circulating cell-free DNA (cfDNA) and RNA from blood plasma or serum. Genomic DNA Isolation and purification focuses on extracting DNA from the genome, yielding a comprehensive map of genetic information. The purified genomic DNA is applied in various areas, including genealogy, pharmacogenomics, and disease research. Messenger RNA isolation and purification targets messenger RNA (mRNA), and this technique plays a vital role in studying gene regulation. It provides critical insights into gene expression profiles, aiding therapeutic research for cancer and neurological disorders. Micro RNA isolation and purification focuses on micro RNA (miRNA), small non-coding RNA molecules that regulate gene expression. Exploring miRNA has profound implications for understanding diseases at the molecular level, especially oncology, cardiology, and virology. PCR Cleanup is a technique to purify PCR amplification products. Removing primers, nucleotides, enzymes, and salts is vital, which may interfere with subsequent enzymatic reactions. Plasmid DNA isolation and purification targeting plasmid DNA isolation is essential for genetic engineering and gene cloning. As genetic carriers, plasmids have significant biotechnological applications, including gene therapy and vaccine development. The total RNA Isolation and purification method aims to obtain all types of RNA, including mRNA, tRNA, and rRNA. It's pivotal in various fields of study, notably in exploring the transcriptome for understanding gene function, structure, and expression. Illustratively, the isolation and purification method choice pivots on the specific nucleic acid type and research necessity. Advancements in these techniques are continually broadening the scope, invigorating unprecedented opportunities in the genomic and genetic research sphere.

Application: Wider application of nucleic acid isolation & purification in diagnostics to provide guidance on therapy

In agriculture and animal research, nucleic acid helps to detect genetically modified organisms (GMOs), identify pathogens in crops and livestock, and facilitate selective breeding for desirable traits. Advancements in nucleic acid extraction techniques have allowed researchers to detect diseases early and develop effective treatment strategies for infected plants or animals. In diagnostics, rapid isolation & purification of nucleic acids are essential for identifying infectious agents such as bacteria or viruses, assisting healthcare professionals to diagnose diseases and take timely medical interventions accurately. Drug discovery and development rely heavily on nucleic acid analysis to identify target molecules associated with specific diseases. Researchers can assess drug efficacy and predict potential side effects by examining the behavior of genes in response to new therapeutic compounds. Personalized medicine uses nucleic acid information for tailoring individualized treatments based on a patient's genetic makeup. This approach allows healthcare providers to optimize therapeutic regimens by considering factors such as drug metabolism or predisposition toward certain diseases. As a result, personalized medicine promises improved treatment outcomes while reducing potential adverse reactions.

End User: Growing usage of nucleic acid isolation & purification by the CROs for reliable results, and fast turnaround time

Academic and government research institutions predominantly use nucleic acid isolation and purification techniques for genetics and molecular biology research. Here, stringent quality standards and the ability to handle a broad range of sample types, including more challenging ones, are critical. Contract research organizations (CROs) regularly deal with drug discovery, preclinical studies, and clinical trials, where precise and high-throughput nucleic acid isolation is vital. They seek solutions with reliable results, scalability, and fast turnaround time. In clinical diagnostics, the accuracy and stability of purification protocols are essential. With the growing importance of genetic testing and personalized medicine in patient care, hospitals, and diagnostic centers need more rapid, sensitive, and scalable kits. Pharmaceutical and biotechnology companies often work on developing novel therapeutics and diagnostic assays. They require highly reliable and scalable techniques for nucleic acid isolation - especially in the production of diagnostics, vaccines, and biopharmaceuticals. Although all end users value reliability, scalability, and quick turnaround time, each has unique requirements influenced by its specific work sector. Consideration of these needs is essential for manufacturers to improve nucleic acid isolation and purification techniques.

Regional Insights

In the Americas, the market is fueled by strong research and development investments in the biotechnology and pharmaceutical sectors and rising incidences of genetic disorders. The increasing molecular biology techniques, the rising prevalence of chronic diseases, and the accelerating need for personalized medicine have enhanced the need for nucleic acid extraction methods in the region. Furthermore, the presence of key organizations, such as Thermo Fisher Scientific Inc., QIAGEN N.V., and Illumina Inc., has been pushing product innovation to cater to the growing demand from research labs and diagnostic centers. The EMEA region is witnessing substantial progress due to increased healthcare expenditure by governments and private entities within Europe's aging population. Additionally, countries within the Middle East and Africa invest heavily in medical infrastructure development projects, further enhancing regional market prospects. The collaboration between numerous universities and research institutes has also accelerated scientific progress in nucleic acid isolation methods. APAC region holds immense potential for expansion of the nucleic acid isolation & purification market due to its rapidly developing healthcare sector, increasing government support for life science research, and high population base. Moreover, Emerging economies, such as China, India, Japan, South Korea, and Australia, present lucrative opportunities for industry stakeholders to tap into unexplored areas of growth potential. In conclusion, the nucleic acid isolation & purification market demonstrates a positive trend across the Americas, EMEA, and APAC regions owing to technological advancements and growing disease prevalence rates necessitating efficient diagnosis and therapeutic interventions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nucleic Acid Isolation & Purification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nucleic Acid Isolation & Purification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Isolation & Purification Market, highlighting leading vendors and their innovative profiles. These include A&A Biotechnology, Abcam PLC, ABNova Corporation, Agilent Technologies Inc., Analytik Jena GmbH+Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomatik Corporation, Bioneer Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., Genaxxon bioscience GmbH, Geneaid Biotech Ltd., GeneProof a.s, Genscript Biotech, Hamilton Company, HiMedia Laboratories Private Limited, Illumina Inc., MACHEREY-NAGEL GmbH & Co. KG, Merck KGaA, MP Biomedicals, New England Biolabs, Inc., Norgen Biotec Corp., NZYTech, Omega Bio-tek, Inc., Perkin Elmer Inc., Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Isolation & Purification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Instruments
  • Kits
  • Reagents

• Method
  • Column-Based Isolation & Purification
  • Magnetic Bead-Based Isolation & Purification
  • Reagent-Based Isolation & Purification

• Type
  • Circulating Nucleic Acid Isolation & Purification
  • Genomic DNA Isolation & Purification
  • Messenger RNA Isolation & Purification
  • Micro RNA Isolation & Purification
  • PCR Cleanup
  • Plasmid DNA Isolation & Purification
  • Total RNA Isolation & Purification

• Application
  • Agriculture & Animal Research
  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine

• End User
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nucleic Acid Isolation & Purification Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nucleic Acid Isolation & Purification Market?

3. What are the technology trends and regulatory frameworks in the Nucleic Acid Isolation & Purification Market?

4. What is the market share of the leading vendors in the Nucleic Acid Isolation & Purification Market?

5. Which modes and strategic moves are suitable for entering the Nucleic Acid Isolation & Purification Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand of pure nucleic acids in pharmaceutical and biotechnological industries
    • 5.1.1.2. Favorable government guidelines and regulations for DNA extraction process
    • 5.1.1.3. Increasing funding in genetic engineering, life science research, and forensics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of set-up for nucleic acid isolation & purification
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging innovations in nucleic acid extraction and purification techniques
    • 5.1.3.2. Potential developments to extract DNA from plant and animal cells
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of subject matter expertise in the field of nucleic acid
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing demand for automation instruments to reduce the time for routine tasks
  • 5.2.2. Method: Significant adoption of column-based isolation & purification owing to scalability, allowing effective purification and isolation irrespective of the sample size

5.2.3. Type:

• 5.2.4. Application: Wider application of nucleic acid isolation & purification in diagnostics to provide guidance on therapy
• 5.2.5. End User: Growing usage of nucleic acid isolation & purification by the CROs for reliable results, and fast turnaround time
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Nucleic Acid Isolation & Purification Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits
• 6.4. Reagents

7. Nucleic Acid Isolation & Purification Market, by Method

• 7.1. Introduction
• 7.2. Column-Based Isolation & Purification
• 7.3. Magnetic Bead-Based Isolation & Purification
• 7.4. Reagent-Based Isolation & Purification

8. Nucleic Acid Isolation & Purification Market, by Type

• 8.1. Introduction
• 8.2. Circulating Nucleic Acid Isolation & Purification
• 8.3. Genomic DNA Isolation & Purification
• 8.4. Messenger RNA Isolation & Purification
• 8.5. Micro RNA Isolation & Purification
• 8.6. PCR Cleanup
• 8.7. Plasmid DNA Isolation & Purification
• 8.8. Total RNA Isolation & Purification

9. Nucleic Acid Isolation & Purification Market, by Application

• 9.1. Introduction
• 9.2. Agriculture & Animal Research
• 9.3. Diagnostics
• 9.4. Drug Discovery & Development
• 9.5. Personalized Medicine

10. Nucleic Acid Isolation & Purification Market, by End User

• 10.1. Introduction
• 10.2. Academic & Government Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Hospitals & Diagnostic Centers
• 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Nucleic Acid Isolation & Purification Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Nucleic Acid Isolation & Purification Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Nucleic Acid Isolation & Purification Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. BioEcho Launches EchoLUTION FFPE DNA Kit for a Simplified DNA Extraction from FFPE Samples
  • 14.3.2. Invitek Molecular acquired by ALS Limited
  • 14.3.3. Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System
• 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio